Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy

This publication has 100 references indexed in Scilit:

• Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer
  Cancer Treatment Reviews, 2006
• Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study
  Radiotherapy and Oncology, 2005
• Interactions of the integrin subunit β1A with protein kinase B/Akt, p130Cas and paxillin contribute to regulation of radiation survival
  Radiotherapy and Oncology, 2005
• The role of apoptosis in cancer development and treatment response
  Nature Reviews Cancer, 2005
• Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy
  Radiotherapy and Oncology, 2004
• Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial
  Radiotherapy and Oncology, 2004
• Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy
  Radiotherapy and Oncology, 2004
• Molecular markers in clinical radiation oncology
  Oncogene, 2003
• Low-dose hypersensitivity after fractionated low-dose irradiation in vitro
  International Journal of Radiation Biology, 2001
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999